We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.8B
AUM Growth
-$159M
Cap. Flow
-$187M
Cap. Flow %
-3.89%
Top 10 Hldgs %
18.32%
Holding
695
New
64
Increased
242
Reduced
263
Closed
62

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$40.8M
2
INTU icon
Intuit
INTU
+$32.8M
3
META icon
Meta Platforms (Facebook)
META
+$30.3M
4
MA icon
Mastercard
MA
+$28.3M
5
NKE icon
Nike
NKE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 29.43%
2 Financials 13.37%
3 Technology 9.86%
4 Consumer Discretionary 7.77%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$120B
$32.6M 0.68%
263,854
+42,000
+19% +$5.29M
GAP
27
The Gap Inc
GAP
$6.8B
$32.6M 0.68%
852,890
+654,437
+330% +$25.8M
KO icon
28
Coca-Cola
KO
$349B
$31.4M 0.65%
799,676
-88,995
-10% -$3.62M
JPM icon
29
JPMorgan Chase
JPM
$930B
$30.6M 0.64%
451,016
+83,494
+23% +$5.45M
PH icon
30
Parker-Hannifin
PH
$124B
$30.4M 0.63%
261,646
-40,063
-13% -$4.84M
HD icon
31
Home Depot
HD
$324B
$29.3M 0.61%
263,620
-27,355
-9% -$3.06M
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.06T
$29.2M 0.61%
214,863
-34,161
-14% -$4.87M
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.4B
$29.2M 0.61%
213,751
+2,976
+1% +$369K
TRV icon
34
Travelers Companies
TRV
$78.5B
$29.1M 0.61%
301,288
+116,856
+63% +$12M
ALL icon
35
Allstate
ALL
$65.5B
$28.7M 0.6%
442,012
+58,605
+15% +$4.02M
CMA
36
DELISTED
Comerica
CMA
$28.3M 0.59%
552,057
-12,572
-2% -$612K
PM icon
37
Philip Morris
PM
$298B
$28.1M 0.59%
350,973
-59,092
-14% -$4.86M
INCY icon
38
Incyte
INCY
$23.3B
$27.4M 0.57%
263,172
+8,304
+3% +$860K
WFC icon
39
Wells Fargo
WFC
$261B
$27.1M 0.56%
482,616
+89,743
+23% +$5M
OXY icon
40
Occidental Petroleum
OXY
$57.3B
$26.4M 0.55%
340,577
+74,533
+28% +$5.82M
CBRE icon
41
CBRE Group
CBRE
$39.7B
$26.4M 0.55%
713,565
-57,685
-7% -$2.19M
GE icon
42
GE Aerospace
GE
$362B
$26M 0.54%
204,230
-13,954
-6% -$1.81M
AIZ icon
43
Assurant
AIZ
$13.6B
$25.9M 0.54%
386,441
+64,225
+20% +$4.14M
AXP icon
44
American Express
AXP
$233B
$25.3M 0.53%
324,945
-70,746
-18% -$5.61M
LM
45
DELISTED
Legg Mason, Inc.
LM
$25.2M 0.52%
488,760
+19,215
+4% +$1.03M
K
46
DELISTED
Kellanova
K
$25.2M 0.52%
427,771
+263,202
+160% +$15.7M
CVX icon
47
Chevron
CVX
$387B
$24.9M 0.52%
257,596
+146,232
+131% +$15.4M
ILMN icon
48
Illumina
ILMN
$29.8B
$23.8M 0.5%
112,137
+4,111
+4% +$803K
KDP icon
49
Keurig Dr Pepper
KDP
$40.4B
$23.1M 0.48%
317,106
+22,067
+7% +$1.68M
HBAN icon
50
Huntington Bancshares
HBAN
$35.2B
$22.8M 0.47%
2,015,798
-505,525
-20% -$5.66M

Similar funds

Candriam SCA's Q2 2015 Portfolio in Review

As of Q2 2015, Candriam SCA held 695 positions worth $4.8B, down 3.2% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $187M in Q2 2015, closing 62 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Japan ETF, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in American Airlines Group worth $11.6M.

  • Candriam SCA's largest Q2 2015 buy was American Airlines Group: 290,014 shares worth $11.6M.
  • Candriam SCA added most to Alphabet (Google) Class C in Q2 2015, an estimated $33.8M increase.
  • Candriam SCA's biggest Q2 2015 reduction was Intuit, cutting an estimated $32.8M.
  • Candriam SCA fully exited iShares MSCI Japan ETF in Q2 2015, selling an estimated $40.8M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.8B portfolio in Q2 2015.
  • Candriam SCA opened 64 new positions and closed 62 in Q2 2015.
  • Candriam SCA's portfolio value fell 3.2% quarter-over-quarter to $4.8B.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.